BACKGROUND: Current research suggests that stressful life experiences and situations create a substantive effect in the development of the initial manifestations of psychotic disorders and may influence temporo-limbic epileptic-like activity manifesting as cognitive and affective seizure-like symptoms in non-epileptic conditions. METHODS: The current study assessed trauma history, hair cortisol levels, epileptic-like manifestations and other psychopathological symptoms in 56 drug naive adult young women experiencing their initial occurrence of psychosis. RESULTS: Hair cortisol levels among patients experiencing their initial episode of psychosis, were significantly correlated with stress symptoms measured by Trauma Symptom Checklist-40 (r = - 0.48, p < 0.01), and complex partial seizure-like symptoms measured by the Complex Partial Seizure-Like Symptoms Inventory (r = - 0.33, p < 0.05) and LSCL-33 (r = - 0.33, p < 0.05). Hair cortisol levels were not found to be significantly correlated with symptoms of anxiety and depression measured by Beck depression Inventory and Zung Anxiety Scale. CONCLUSION: These findings suggest a significant relationship between epileptic-like symptoms and stress responses demonstrated by patients in their first psychotic episode. These findings may suggest the potential for research to explore usefulness of anticonvulsant treatment in patients who do not respond to usual psychotropic medication.

Center for Neuropsychiatric Research of Traumatic Stress Department of Psychiatry and UHSL 1st Faculty of Medicine and Department of Psychiatry Faculty of Medicine Pilsen Charles University Prague Prague Czechia

Roudebush VA Medical Center and the Indiana University School of Medicine Indianapolis IN United States

Rush University Medical Center Chicago IL United States

Zobrazit více v PubMed

American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). American Psychiatric Publishing, Inc.

Beck A. T., Steer R., Brown G. (1987). Beck Depression Inventory Manual. San Antonio, TX: The Psychological Corporation.

Beck A. T., Ward C. H., Mendelson M., Mock J., Erbaugh J. (1961). An inventory for measuring depression. Arch. Gener. Psychiatry 4 561–571. 10.1001/archpsyc.1961.01710120031004 PubMed DOI

Benes F. M., Berretta S. (2001). GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology 25 1–27. 10.1016/S0893-133X(01)00225-1 PubMed DOI

Bertram E. (2007). The relevance of kindling for human epilepsy. Epilepsia 48 65–74. 10.1111/j.1528-1167.2007.01068.x PubMed DOI

Bob P. (2013). Stress Sensitization and Anticonvulsant Medication in Psychiatric Patients in Polypharmacy in Psychiatry Practice. Berlin: Springer, 233–242.

Bob P., Jasova D., Raboch J. (2011). Subclinical epileptiform process in patients with unipolar depression and its indirect psychophysiological manifestations. PLoS One 6:e28041. 10.1371/journal.pone.0028041 PubMed DOI PMC

Bob P., Palus M., Susta M., Glaslova K. (2010). Sensitization, epileptic-like symptoms and local synchronization in patients with paranoid schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 34 143–146. 10.1016/j.pnpbp.2009.10.015 PubMed DOI

Bob P., Pec O., Mishara A. L., Touskova T., Lysaker P. H. (2016). Conscious brain, metacognition and schizophrenia. Int. J. Psychophysiol. 105 1–8. 10.1016/j.ijpsycho.2016.05.003 PubMed DOI

Boutros N. N., Ghosh S., Khan A., Bowyer S. M., Galloway M. P. (2014). Anticonvulsant medications for panic disorder: a review and synthesis of the evidence. Int. J. Psychiatry Clin. Pract. 18 2–10. 10.3109/13651501.2013.873053 PubMed DOI

Castner S. A., Williams G. V. (2007). From vice to virtue: insights from sensitization in the nonhuman primate. Prog. Neuropsychopharmacol. Biol. Psychiatry 31 1572–1592. 10.1016/j.pnpbp.2007.08.026 PubMed DOI

Chaumette B., Kebir O., Mam-Lam-Fook C., Morvan Y., Bourgin J., Godsil B. P., et al. (2016). Salivary cortisol in early psychosis: new findings and meta-analysis. Psychoneuroendocrinology 63 262–270. 10.1016/j.psyneuen.2015.10.007 PubMed DOI

Collip D., Myin-Germeys I., Van Os J. (2008). Does the concept of “sensitization” provide a plausible mechanism for the putative link between the environment and schizophrenia? Schizophr. Bull. 34 220–225. 10.1093/schbul/sbm163 PubMed DOI PMC

Costa E., Davis J. M., Dong E., Grayson D. R., Guidotti A., Tremolizzo L., et al. (2004). A GABAergic cortical deficit dominates schizophrenia pathophysiology. Crit. Rev. Neurobiol. 16 1–23. 10.1615/critrevneurobiol.v16.i12.10 PubMed DOI

Eack S. M., Prasad K. M., Montrose D. M., Goradia D. D., Dworakowski D., Miewald J., et al. (2008). An integrated psychobiological predictive model of emergent psychopathology among young relatives at risk for schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 32 1873–1878. 10.1016/j.pnpbp.2008.08.024 PubMed DOI PMC

Elliott D. M., Briere J. (1992). Sexual abuse trauma among professional women: validating the Trauma Symptom Checklist-40 (TSC-40). Child Abuse Negl. 16 391–398. 10.1016/0145-2134(92)90048-v PubMed DOI

Faravelli C., Mansueto G., Palmieri S., Sauro C. L., Rotella F., Pietrini F., et al. (2017). Childhood adversity, cortisol levels, and psychosis: a retrospective investigation. J. Nervous Ment. Dis. 205 574–579. 10.1097/NMD.0000000000000699 PubMed DOI

Girshkin L., Matheson S. L., Shepherd A. M., Green M. J. (2014). Morning cortisol levels in schizophrenia and bipolar disorder: a meta-analysis. Psychoneuroendocrinology 49 187–206. 10.1016/j.psyneuen.2014.07.013 PubMed DOI

Glenthoj B. Y., Hemmingsen R. (1997). Dopaminergic sensitization: implications for the pathogenesis of schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 21 23–46. 10.1016/s0278-5846(96)00158-3 PubMed DOI

Goddard G. V., Mcintyre D. C., Leech C. K. (1969). A permanent change in brain function resulting from daily electrical stimulation. Exp. Neurol. 25 295–330. 10.1016/0014-4886(69)90128-9 PubMed DOI

Gomes R. R., Vicente V. A., Azevedo C. M., Salgado C. G., Da Silva M. B., Queiroz-Telles F., et al. (2016). Molecular epidemiology of agents of human chromoblastomycosis in brazil with the description of two novel species. PLoS Negl. Trop. Dis. 10:5102. PubMed PMC

Gonzalez-Burgos G., Lewis D. A. (2008). GABA neurons and the mechanisms of network oscillations: implications for understanding cortical dysfunction in schizophrenia. Schizophr. Bull. 34 944–961. 10.1093/schbul/sbn070 PubMed DOI PMC

Gow R., Thomson S., Rieder M., Van Uum S., Koren G. (2010). An assessment of cortisol analysis in hair and its clinical applications. Forensic. Sci. Int. 196 32–37. 10.1016/j.forsciint.2009.12.040 PubMed DOI

Heckers S., Konradi C. (2002). Hippocampal neurons in schizophrenia. J. Neural. Transm. 109 891–905. 10.1007/s007020200073 PubMed DOI PMC

Howes O. D., Mccutcheon R., Owen M. J., Murray R. M. (2017). The role of genes, stress, and dopamine in the development of schizophrenia. Biol. Psychiatry 81 9–20. 10.1016/j.biopsych.2016.07.014 PubMed DOI PMC

Jacob T. C., Moss S. J., Jurd R. (2008). GABA(A) receptor trafficking and its role in the dynamic modulation of neuronal inhibition. Nat. Rev. Neurosci. 9 331–343. 10.1038/nrn2370 PubMed DOI PMC

Johannessen Landmark C. (2008). Antiepileptic drugs in non-epilepsy disorders: relations between mechanisms of action and clinical efficacy. CNS Drugs 22 27–47. 10.2165/00023210-200822010-00003 PubMed DOI

Kaufman K. R. (2011). Antiepileptic drugs in the treatment of psychiatric disorders. Epilep. Behav. 21 1–11. 10.1016/j.yebeh.2011.03.011 PubMed DOI

Kay S. R., Fiszbein A., Opler L. A. (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 13 261–276. 10.1093/schbul/13.2.261 PubMed DOI

Kraus J. E. (2000). Sensitization phenomena in psychiatric illness: lessons from the kindling model. J. Neuropsych. Clin. Neurosci. 12 328–343. 10.1176/jnp.12.3.328 PubMed DOI

Mayo D., Corey S., Kelly L. H., Yohannes S., Youngquist A. L., Stuart B. K., et al. (2017). The role of trauma and stressful life events among individuals at clinical high risk for psychosis: a review. Front. Psychiatry 8:55. 10.3389/fpsyt.2017.00055 PubMed DOI PMC

Meyer J. S., Novak M. A. (2012). Minireview: Hair cortisol: a novel biomarker of hypothalamic-pituitary-adrenocortical activity. Endocrinology 153 4120–4127. 10.1210/en.2012-1226 PubMed DOI PMC

Mohler H. (2006). GABA(A) receptor diversity and pharmacology. Cell Tissue Res. 326 505–516. 10.1007/s00441-006-0284-3 PubMed DOI

Phillips T. J., Roberts A. J., Lessov C. N. (1997). Behavioral sensitization to ethanol: genetics and the effects of stress. Pharmacol. Biochem. Behav. 57 487–493. 10.1016/s0091-3057(96)00448-0 PubMed DOI

Post R. M., Weiss S. R. (1996). A speculative model of affective illness cyclicity based on patterns of drug tolerance observed in amygdala-kindled seizures. Mol. Neurobiol. 13 33–60. 10.1007/BF02740751 PubMed DOI

Post R. M., Weiss S. R., Smith M., Li H., Mccann U. (1997). Kindling versus quenching. Implications for the evolution and treatment of posttraumatic stress disorder. Ann. NY Acad. Sci. 821 285–295. 10.1111/j.1749-6632.1997.tb48287.x PubMed DOI

Pruessner M., Cullen A. E., Aas M., Walker E. F. (2017). The neural diathesis-stress model of schizophrenia revisited: an update on recent findings considering illness stage and neurobiological and methodological complexities. Neurosci. Biobehav. Rev. 73 191–218. 10.1016/j.neubiorev.2016.12.013 PubMed DOI

Reininghaus U., Kempton M. J., Valmaggia L., Craig T. K., Garety P., Onyejiaka A., et al. (2016). Stress sensitivity, aberrant salience, and threat anticipation in early psychosis: an experience sampling study. Schizophr. Bull. 42 712–722. 10.1093/schbul/sbv190 PubMed DOI PMC

Roberts R. J., Gorman L. L., Lee G. P., Hines M. E., Richardson E. D., Riggle T. A., et al. (1992). The phenomenology of multiple partial seizure-like symptoms without stereotyped spells: an epilepsy spectrum disorder? Epilep. Res. 13 167–177. 10.1016/0920-1211(92)90073-3 PubMed DOI

Russell E., Koren G., Rieder M., Van Uum S. (2012). Hair cortisol as a biological marker of chronic stress: current status, future directions and unanswered questions. Psychoneuroendocrinology 37 589–601. 10.1016/j.psyneuen.2011.09.009 PubMed DOI

Ryan M. C., Sharifi N., Condren R., Thakore J. H. (2004). Evidence of basal pituitary-adrenal overactivity in first episode, drug naive patients with schizophrenia. Psychoneuroendocrinology 29 1065–1070. 10.1016/j.psyneuen.2003.08.011 PubMed DOI

Sauvé B., Koren G., Walsh G., Tokmakejian S., Van Uum S. H. (2007). Measurement of cortisol in human hair as a biomarker of systemic exposure. Clin. Invest. Med. 2007 E183–E191. 10.25011/cim.v30i5.2894 PubMed DOI

Sheehan D. V., Lecrubier Y., Sheehan K. H., Amorim P., Janavs J., Weiller E., et al. (1998). The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry 59 22–33. PubMed

Silberman E. K., Post R. M., Nurnberger J., Theodore W., Boulenger J. P. (1985). Transient sensory, cognitive and affective phenomena in affective illness. A comparison with complex partial epilepsy. Br. J. Psychiatry 146 81–89. 10.1192/bjp.146.1.81 PubMed DOI

Stalder T., Steudte-Schmiedgen S., Alexander N., Klucken T., Vater A., Wichmann S., et al. (2017). Stress-related and basic determinants of hair cortisol in humans: a meta-analysis. Psychoneuroendocrinology 77 261–274. 10.1016/j.psyneuen.2016.12.017 PubMed DOI

Stephens D. W., Mclinn C. M., Stevens J. R. (2002). Discounting and reciprocity in an Iterated Prisoner’s Dilemma. Science 298 2216–2218. 10.1126/science.1078498 PubMed DOI

Stephens D. W., Mclinn C. M., Stevens J. R. (2006). Effects of temporal clumping and payoff accumulation on impulsiveness and cooperation. Behav. Proc. 71 29–40. 10.1016/j.beproc.2005.09.003 PubMed DOI

Steudte-Schmiedgen S., Wichmann S., Stalder T., Hilbert K., Muehlhan M., Lueken U., et al. (2017). Hair cortisol concentrations and cortisol stress reactivity in generalized anxiety disorder, major depression and their comorbidity. J. Psychiatric Res. 84 184–190. 10.1016/j.jpsychires.2016.09.024 PubMed DOI

Streit F., Memic A., Hasandedic L., Rietschel L., Frank J., Lang M., et al. (2016). Perceived stress and hair cortisol: differences in bipolar disorder and schizophrenia. Psychoneuroendocrinology 69 26–34. 10.1016/j.psyneuen.2016.03.010 PubMed DOI

Teicher M. H., Andersen S. L., Polcari A., Anderson C. M., Navalta C. P., Kim D. M. (2003). The neurobiological consequences of early stress and childhood maltreatment. Neurosci. Biobehav. Rev. 27 33–44. 10.1016/s0149-7634(03)00007-1 PubMed DOI

Teicher M. H., Glod C. A., Surrey J., Swett C., Jr. (1993). Early childhood abuse and limbic system ratings in adult psychiatric outpatients. J. Neuropsych. Clin. Neurosci. 5 301–306. 10.1176/jnp.5.3.301 PubMed DOI

Teicher M. H., Tomoda A., Andersen S. L. (2006). Neurobiological consequences of early stress and childhood maltreatment: are results from human and animal studies comparable? Ann. NY Acad. Sci. 1071 313–323. 10.1196/annals.1364.024 PubMed DOI

Tiihonen J., Wahlbeck K., Kiviniemi V. (2009). The efficacy of lamotrigine in clozapine-resistant schizophrenia: a systematic review and meta-analysis. Schizophr. Res. 109 10–14. 10.1016/j.schres.2009.01.002 PubMed DOI

van Os J., Rutten B. P., Poulton R. (2008). Gene-environment interactions in schizophrenia: review of epidemiological findings and future directions. Schizophr. Bull. 34 1066–1082. 10.1093/schbul/sbn117 PubMed DOI PMC

van Winkel R., Stefanis N. C., Myin-Germeys I. (2008). Psychosocial stress and psychosis. A review of the neurobiological mechanisms and the evidence for gene-stress interaction. Schizophr. Bull. 34 1095–1105. 10.1093/schbul/sbn101 PubMed DOI PMC

Varese F., Smeets F., Drukker M., Lieverse R., Lataster T., Viechtbauer W., et al. (2012). Childhood adversities increase the risk of psychosis: a meta-analysis of patient-control, prospective- and cross-sectional cohort studies. Schizophr. Bull. 38 661–671. 10.1093/schbul/sbs050 PubMed DOI PMC

Walker E. F., Diforio D. (1997). Schizophrenia: a neural diathesis-stress model. Psychol. Rev. 104 667–685. 10.1037/0033-295x.104.4.667 PubMed DOI

Weidenauer A., Bauer M., Sauerzopf U., Bartova L., Praschak-Rieder N., Sitte H. H., et al. (2017). Making sense of: sensitization in schizophrenia. Int. J. Neuropsychopharmacol. 20 1–10. 10.1093/ijnp/pyw081 PubMed DOI PMC

Yuii K., Suzuki M., Kurachi M. (2007). Stress sensitization in schizophrenia. Ann. NY Acad. Sci. 1113 276–290. 10.1196/annals.1391.013 PubMed DOI

Zung W. W. (1971). A rating instrument for anxiety disorders. Psychosomatics 12 371–379. 10.1016/S0033-3182(71)71479-0 PubMed DOI

Fear of Flying, Stress and Epileptic-Like Symptoms